Skip to content
Congress·In Committee·about 1 month ago

Prescription Drug Pricing: Study on Supply Chain Fees

Also known as: Prescription Drug Supply Chain Pricing Transparency Act

Legislative Progress

✓ Filed
Review
Senate
House
President

Key Points

  • Senators Bennet and Lankford introduced a bill to investigate how "middleman" companies in the drug industry make their money and how that affects what you pay at the pharmacy.
  • The study will look at whether companies that manage drug benefits and insurance providers are getting paid fees based on a percentage of a drug's high price.
  • Investigators will look for conflicts of interest, such as whether these companies choose expensive drugs over cheaper ones just to collect higher fees.
  • The goal is to uncover hidden deals that might be making medicine more expensive for people using government programs like Medicare and Medicaid.
  • The government watchdog must finish this study and give Congress a list of ways to fix these pricing problems within two years.

Milestones

2 milestones2 actions
Jan 29, 2026Senate

Read twice and referred to the Committee on Finance.

Jan 29, 2026

Introduced in Senate

Source Information

Document Type

Congressional Bill

Official Title

Prescription Drug Supply Chain Pricing Transparency Act

Bill NumberS 3751
Congress119th Congress
ChamberSenate
Latest ActionRead twice and referred to the Committee on Finance.

Sponsor

Cosponsors

(1)
R: 1

Analysis generated by AI. While we strive for accuracy, this should not be considered legal or professional advice. Always verify information with official government sources.